
WDNA ETF Holdings: WisdomTree BioRevolution Fund
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 | ![]() | Twist Bioscience Corporation | Stock | 5.27% |
| 2 | ![]() | Eli Lilly and Company | Stock | 4.46% |
| 3 | ![]() | Moderna, Inc. | Stock | 3.48% |
| 4 | ![]() | Johnson & Johnson | Stock | 3.16% |
| 5 | ![]() | United Therapeutics Corporation | Stock | 2.88% |
| 6 | ![]() | Darling Ingredients Inc | Stock | 2.44% |
| 7 | ![]() | Tempus AI, Inc. | Stock | 2.32% |
| 8 | ![]() | Immunome, Inc | Stock | 2.29% |
| 9 | ![]() | Stoke Therapeutics, Inc | Stock | 2.22% |
| 10 | ![]() | Natera, Inc | Stock | 2.14% |
| 11 | ![]() | Beam Therapeutics Inc. | Stock | 2.13% |
| 12 | ![]() | Corteva, Inc | Stock | 2.10% |
| 13 | L LSE:AZN | AstraZeneca PLC | Stock | 2.08% |
| 14 | ![]() | Bunge Limited | Stock | 2.07% |
| 15 | ![]() | Ionis Pharmaceuticals, Inc | Stock | 2.02% |
| 16 | ![]() | CRISPR Therapeutics AG | Stock | 1.95% |
| 17 | L LON:AZN | AstraZeneca PLC | Stock | 1.93% |
| 18 | ![]() | Krystal Biotech, Inc. | Stock | 1.93% |
| 19 | ![]() | Structure Therapeutics Inc. | Stock | 1.91% |
| 20 | ![]() | Gilead Sciences, Inc | Stock | 1.79% |
| 21 | ![]() | Amgen Inc | Stock | 1.73% |
| 22 | ![]() | 10x Genomics, Inc. | Stock | 1.71% |
| 23 | ![]() | Pfizer Inc | Stock | 1.68% |
| 24 | ![]() | Roivant Sciences Ltd. | Stock | 1.66% |
| 25 | ![]() | Thermo Fisher Scientific Inc | Stock | 1.66% |
| 26 | ![]() | Revolution Medicines, Inc. | Stock | 1.62% |
| 27 | ![]() | Arrowhead Pharmaceuticals, Inc | Stock | 1.53% |
| 28 | S SWX:NOVN | Novartis AG | Stock | 1.46% |
| 29 | C CO:NSIS.B | Novozymes A/S Class B | Stock | 1.43% |
| 30 | ![]() | Veracyte, Inc | Stock | 1.41% |
| 31 | ![]() | Vertex Pharmaceuticals Incorporated | Stock | 1.39% |
| 32 | ![]() | Agios Pharmaceuticals, Inc | Stock | 1.39% |
| 33 | E ETR:BAYN | Bayer Aktiengesellschaft | Stock | 1.34% |
| 34 | ![]() | Catalyst Pharmaceuticals Inc | Stock | 1.24% |
| 35 | ![]() | Exelixis, Inc | Stock | 1.17% |
| 36 | ![]() | Absci Corp | Stock | 1.09% |
| 37 | ![]() | argenx NV ADR | Stock | 1.04% |
| 38 | E ETR:VBK | VERBIO Vereinigte BioEnergie AG | Stock | 0.98% |
| 39 | ![]() | BioNTech SE | Stock | 0.96% |
| 40 | ![]() | Protagonist Therapeutics Inc | Stock | 0.94% |
| 41 | ![]() | Editas Medicine, Inc | Stock | 0.92% |
| 42 | ![]() | Iovance Biotherapeutics, Inc | Stock | 0.91% |
| 43 | ![]() | Cullinan Management, Inc | Stock | 0.90% |
| 44 | ![]() | Dyne Therapeutics Inc | Stock | 0.89% |
| 45 | ![]() | Biogen Inc | Stock | 0.86% |
| 46 | ![]() | Celldex Therapeutics Inc | Stock | 0.86% |
| 47 | ![]() | Allogene Therapeutics, Inc | Stock | 0.86% |
| 48 | ![]() | Danaher Corporation | Stock | 0.84% |
| 49 | ![]() | uniQure N.V | Stock | 0.82% |
| 50 | ![]() | CG Oncology, Inc. Common stock | Stock | 0.79% |
Frequently Asked Questions About WisdomTree BioRevolution Fund Holdings
What are the top holdings in WDNA?
WisdomTree BioRevolution Fund (WDNA) holds 80 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is WDNA's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review WDNA's holdings table to analyze concentration risk.
What is WDNA's sector allocation?
The Sector Allocation chart shows how WDNA distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does WDNA invest in?
WDNA's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is WDNA ETF?
WDNA's diversification can be assessed by reviewing its 80 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.











































